Home > Research > Publications & Outputs > An empirical survey on biobanking of human gene...
View graph of relations

An empirical survey on biobanking of human genetic material and data in six EU countries.

Research output: Contribution to journalJournal article

Published

Standard

An empirical survey on biobanking of human genetic material and data in six EU countries. / Hirtzlin, Isabelle; Dubreuil, Christine; Préaubert, Nathalie; Duchier, Jenny; Jansen, Brigitte; Simon, Jürgen; Lobatao De Faria, Paula; Perez-Lezaun, Anna; Visser, Bert; Williams, Garrath D.; Cambon-Thomsen, Anne; EUROGENBANK consortium, The.

In: European Journal of Human Genetics, Vol. 11, No. 6, 06.2003, p. 475-488.

Research output: Contribution to journalJournal article

Harvard

Hirtzlin, I, Dubreuil, C, Préaubert, N, Duchier, J, Jansen, B, Simon, J, Lobatao De Faria, P, Perez-Lezaun, A, Visser, B, Williams, GD, Cambon-Thomsen, A & EUROGENBANK consortium, T 2003, 'An empirical survey on biobanking of human genetic material and data in six EU countries.', European Journal of Human Genetics, vol. 11, no. 6, pp. 475-488. https://doi.org/10.1038/sj.ejhg.5201007

APA

Hirtzlin, I., Dubreuil, C., Préaubert, N., Duchier, J., Jansen, B., Simon, J., Lobatao De Faria, P., Perez-Lezaun, A., Visser, B., Williams, G. D., Cambon-Thomsen, A., & EUROGENBANK consortium, T. (2003). An empirical survey on biobanking of human genetic material and data in six EU countries. European Journal of Human Genetics, 11(6), 475-488. https://doi.org/10.1038/sj.ejhg.5201007

Vancouver

Hirtzlin I, Dubreuil C, Préaubert N, Duchier J, Jansen B, Simon J et al. An empirical survey on biobanking of human genetic material and data in six EU countries. European Journal of Human Genetics. 2003 Jun;11(6):475-488. https://doi.org/10.1038/sj.ejhg.5201007

Author

Hirtzlin, Isabelle ; Dubreuil, Christine ; Préaubert, Nathalie ; Duchier, Jenny ; Jansen, Brigitte ; Simon, Jürgen ; Lobatao De Faria, Paula ; Perez-Lezaun, Anna ; Visser, Bert ; Williams, Garrath D. ; Cambon-Thomsen, Anne ; EUROGENBANK consortium, The. / An empirical survey on biobanking of human genetic material and data in six EU countries. In: European Journal of Human Genetics. 2003 ; Vol. 11, No. 6. pp. 475-488.

Bibtex

@article{282bea9b61a74eca9f9453f869efd962,
title = "An empirical survey on biobanking of human genetic material and data in six EU countries.",
abstract = "Biobanks correspond to different situations: research and technological development, medical diagnosis or therapeutic activities. Their status is not clearly defined. We aimed to investigate human biobanking in Europe, particularly in relation to organisational, economic and ethical issues in various national contexts. Data from a survey in six EU countries (France, Germany, the Netherlands, Portugal, Spain and the UK) were collected as part of a European Research Project examining human and non-human biobanking (EUROGENBANK, coordinated by Professor JC Galloux). A total of 147 institutions concerned with biobanking of human samples and data were investigated by questionnaires and interviews. Most institutions surveyed belong to the public or private non-profit-making sectors, which have a key role in biobanking. This activity is increasing in all countries because few samples are discarded and genetic research is proliferating. Collections vary in size, many being small and only a few very large. Their purpose is often research, or research and healthcare, mostly in the context of disease studies. A specific budget is very rarely allocated to biobanking and costs are not often evaluated. Samples are usually provided free of charge and gifts and exchanges are the common rule. Good practice guidelines are generally followed and quality controls are performed but quality procedures are not always clearly explained. Associated data are usually computerised (identified or identifiable samples). Biobankers generally favour centralisation of data rather than of samples. Legal and ethical harmonisation within Europe is considered likely to facilitate international collaboration. We propose a series of recommendations and suggestions arising from the EUROGENBANK project.",
keywords = "human biobanking, genetic collection management, Europe, empirical survey, ethics, economics",
author = "Isabelle Hirtzlin and Christine Dubreuil and Nathalie Pr{\'e}aubert and Jenny Duchier and Brigitte Jansen and J{\"u}rgen Simon and {Lobatao De Faria}, Paula and Anna Perez-Lezaun and Bert Visser and Williams, {Garrath D.} and Anne Cambon-Thomsen and {EUROGENBANK consortium}, The",
year = "2003",
month = jun
doi = "10.1038/sj.ejhg.5201007",
language = "English",
volume = "11",
pages = "475--488",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - An empirical survey on biobanking of human genetic material and data in six EU countries.

AU - Hirtzlin, Isabelle

AU - Dubreuil, Christine

AU - Préaubert, Nathalie

AU - Duchier, Jenny

AU - Jansen, Brigitte

AU - Simon, Jürgen

AU - Lobatao De Faria, Paula

AU - Perez-Lezaun, Anna

AU - Visser, Bert

AU - Williams, Garrath D.

AU - Cambon-Thomsen, Anne

AU - EUROGENBANK consortium, The

PY - 2003/6

Y1 - 2003/6

N2 - Biobanks correspond to different situations: research and technological development, medical diagnosis or therapeutic activities. Their status is not clearly defined. We aimed to investigate human biobanking in Europe, particularly in relation to organisational, economic and ethical issues in various national contexts. Data from a survey in six EU countries (France, Germany, the Netherlands, Portugal, Spain and the UK) were collected as part of a European Research Project examining human and non-human biobanking (EUROGENBANK, coordinated by Professor JC Galloux). A total of 147 institutions concerned with biobanking of human samples and data were investigated by questionnaires and interviews. Most institutions surveyed belong to the public or private non-profit-making sectors, which have a key role in biobanking. This activity is increasing in all countries because few samples are discarded and genetic research is proliferating. Collections vary in size, many being small and only a few very large. Their purpose is often research, or research and healthcare, mostly in the context of disease studies. A specific budget is very rarely allocated to biobanking and costs are not often evaluated. Samples are usually provided free of charge and gifts and exchanges are the common rule. Good practice guidelines are generally followed and quality controls are performed but quality procedures are not always clearly explained. Associated data are usually computerised (identified or identifiable samples). Biobankers generally favour centralisation of data rather than of samples. Legal and ethical harmonisation within Europe is considered likely to facilitate international collaboration. We propose a series of recommendations and suggestions arising from the EUROGENBANK project.

AB - Biobanks correspond to different situations: research and technological development, medical diagnosis or therapeutic activities. Their status is not clearly defined. We aimed to investigate human biobanking in Europe, particularly in relation to organisational, economic and ethical issues in various national contexts. Data from a survey in six EU countries (France, Germany, the Netherlands, Portugal, Spain and the UK) were collected as part of a European Research Project examining human and non-human biobanking (EUROGENBANK, coordinated by Professor JC Galloux). A total of 147 institutions concerned with biobanking of human samples and data were investigated by questionnaires and interviews. Most institutions surveyed belong to the public or private non-profit-making sectors, which have a key role in biobanking. This activity is increasing in all countries because few samples are discarded and genetic research is proliferating. Collections vary in size, many being small and only a few very large. Their purpose is often research, or research and healthcare, mostly in the context of disease studies. A specific budget is very rarely allocated to biobanking and costs are not often evaluated. Samples are usually provided free of charge and gifts and exchanges are the common rule. Good practice guidelines are generally followed and quality controls are performed but quality procedures are not always clearly explained. Associated data are usually computerised (identified or identifiable samples). Biobankers generally favour centralisation of data rather than of samples. Legal and ethical harmonisation within Europe is considered likely to facilitate international collaboration. We propose a series of recommendations and suggestions arising from the EUROGENBANK project.

KW - human biobanking

KW - genetic collection management

KW - Europe

KW - empirical survey

KW - ethics

KW - economics

U2 - 10.1038/sj.ejhg.5201007

DO - 10.1038/sj.ejhg.5201007

M3 - Journal article

VL - 11

SP - 475

EP - 488

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 6

ER -